RU2009139259A - Соединения на основе лизина - Google Patents

Соединения на основе лизина Download PDF

Info

Publication number
RU2009139259A
RU2009139259A RU2009139259/04A RU2009139259A RU2009139259A RU 2009139259 A RU2009139259 A RU 2009139259A RU 2009139259/04 A RU2009139259/04 A RU 2009139259/04A RU 2009139259 A RU2009139259 A RU 2009139259A RU 2009139259 A RU2009139259 A RU 2009139259A
Authority
RU
Russia
Prior art keywords
group
compound according
compound
carbon atoms
group containing
Prior art date
Application number
RU2009139259/04A
Other languages
English (en)
Russian (ru)
Inventor
Брент Ричард СТРЭНИКС (CA)
Брент Ричард СТРЭНИКС
Валери ПЕРРОН (CA)
Валери Перрон
Original Assignee
Амбрилиа Байофарма Инк. (Ca)
Амбрилиа Байофарма Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Амбрилиа Байофарма Инк. (Ca), Амбрилиа Байофарма Инк. filed Critical Амбрилиа Байофарма Инк. (Ca)
Publication of RU2009139259A publication Critical patent/RU2009139259A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/41Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215Radicals derived from nitrogen analogues of carbonic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/6533Six-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
RU2009139259/04A 2004-08-02 2009-10-23 Соединения на основе лизина RU2009139259A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CAPCT/CA2004/001440 2004-08-02
PCT/CA2004/001440 WO2006012725A1 (en) 2004-08-02 2004-08-02 Lysine based compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2007107798/04A Division RU2379312C2 (ru) 2004-08-02 2004-08-02 Соединения на основе лизина, фармацевтическая композиция, содержащая эти соединения, применение указанных соединений для лечения или профилактики вич инфекции

Publications (1)

Publication Number Publication Date
RU2009139259A true RU2009139259A (ru) 2011-04-27

Family

ID=35786842

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009139259/04A RU2009139259A (ru) 2004-08-02 2009-10-23 Соединения на основе лизина

Country Status (14)

Country Link
EP (2) EP2165709B1 (https=)
JP (1) JP4579970B2 (https=)
CN (1) CN1942436B (https=)
AT (1) ATE417823T1 (https=)
AU (2) AU2004322123B2 (https=)
BR (1) BRPI0418651A (https=)
CA (1) CA2560071C (https=)
DE (1) DE602004018548D1 (https=)
ES (2) ES2319996T3 (https=)
IL (1) IL180958A0 (https=)
MX (1) MX2007001278A (https=)
NO (1) NO20071152L (https=)
RU (1) RU2009139259A (https=)
WO (1) WO2006012725A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319996T3 (es) 2004-08-02 2009-05-18 Ambrilia Biopharma Inc. Compuestos basados en lisina.
US7388008B2 (en) 2004-08-02 2008-06-17 Ambrilia Biopharma Inc. Lysine based compounds
ES2452718T3 (es) 2005-11-30 2014-04-02 Taimed Biologics, Inc. Profármacos a base de lisina de inhibidores de la aspartil proteasa y procesos para su preparación
WO2008023273A2 (en) * 2006-07-17 2008-02-28 Ambrilia Biopharma Inc. Method for improving pharmacokinetics
CA2664118A1 (en) 2006-09-21 2008-07-03 Ambrilia Biopharma Inc. Protease inhibitors
WO2009148600A2 (en) * 2008-06-06 2009-12-10 Concert Pharmaceuticals, Inc. Deuterated lysine-based compounds
EP2435037B1 (en) 2009-05-27 2014-11-12 Merck Sharp & Dohme Corp. Hiv protease inhibitors
EP2632895B1 (en) 2010-10-28 2018-10-03 Merck Canada Inc. Hiv protease inhibitors
US9187415B2 (en) 2010-10-29 2015-11-17 Merck Canada Inc. Sulfonamides as HIV protease inhibitors
EP2771332B1 (en) 2011-10-26 2016-06-29 Merck Canada Inc. Thiophen and thiazol sulfonamid derivatives as HIV protease inhibitors for the treatment of AIDS

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
WO2001076531A2 (en) * 2000-04-07 2001-10-18 University Of Maryland, Baltimore Bile acid containing prodrugs with enhanced bioavailability
US6617310B2 (en) * 2000-07-19 2003-09-09 Bristol-Myers Squibb Pharma Company Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines
AU8494601A (en) * 2000-08-18 2002-03-04 Univ Illinois Prodrugs of betulinic acid derivatives for the treatment of cancer and HIV
US6506786B2 (en) * 2001-02-13 2003-01-14 Pharmacor Inc. HIV protease inhibitors based on amino acid derivatives
US6632816B1 (en) * 2002-12-23 2003-10-14 Pharmacor Inc. Aromatic derivatives as HIV aspartyl protease inhibitors
ES2319996T3 (es) 2004-08-02 2009-05-18 Ambrilia Biopharma Inc. Compuestos basados en lisina.

Also Published As

Publication number Publication date
BRPI0418651A (pt) 2007-05-29
CN1942436B (zh) 2011-03-23
CA2560071C (en) 2012-09-25
ES2319996T3 (es) 2009-05-18
AU2004322123A1 (en) 2006-02-09
EP2165709A3 (en) 2010-06-23
ATE417823T1 (de) 2009-01-15
AU2004322123B2 (en) 2009-08-13
IL180958A0 (en) 2007-07-04
JP4579970B2 (ja) 2010-11-10
MX2007001278A (es) 2007-09-14
HK1105406A1 (en) 2008-02-15
EP2165709B1 (en) 2016-03-16
AU2009230800A1 (en) 2009-11-19
CN1942436A (zh) 2007-04-04
EP1773763A4 (en) 2007-08-08
EP2165709A2 (en) 2010-03-24
JP2007525527A (ja) 2007-09-06
WO2006012725A1 (en) 2006-02-09
ES2575871T3 (es) 2016-07-01
EP1773763B1 (en) 2008-12-17
EP1773763A1 (en) 2007-04-18
NO20071152L (no) 2007-03-01
CA2560071A1 (en) 2006-02-09
DE602004018548D1 (de) 2009-01-29

Similar Documents

Publication Publication Date Title
RU2009139259A (ru) Соединения на основе лизина
NO2022019I1 (no) Eribulin eller et farmasøytisk akseptabelt salt derav - forlenget SPC
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
ES2102478T3 (es) Complejos de vanadio, su preparacion y composiciones farmaceuticas que los contienen.
RU2008152087A (ru) Макроциклические оксимильные ингибиторы протеазы гепатита
KR920009783A (ko) 인단 및 퀴놀린 유도체
RU2000127105A (ru) Соединения с активностью в отношении мускариновых рецепторов
BR9916790A (pt) Uso de um composto, composto, processo para amanufatura do mesmo, composição farmacêtica, e,método para produzir um efeito de dano vascularem um animal de sangue quente
EA200100983A1 (ru) Производные 13-метилэритромицина
EA200001146A1 (ru) Производные изотиазола, применимые в качестве противораковых агентов
DE68901153D1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
EA200400140A1 (ru) Пероральные противодиабетические агенты
RU2014122866A (ru) Пропеноатные производные бетулина
RU2000115947A (ru) Производные бифениламидина
RU2003133143A (ru) Содержание имидазотриазиноны составы для назального введения
DE3786896D1 (de) Verwendung eines spermin-derivats mit anti-neoplastischer wirkung zur herstellung pharmazeutischer zusammensetzungen.
SE8603098L (sv) Poly-4-aminopyrrol-2-karboxamidoderivat och forfarande for deras framstellning
RU2004102398A (ru) Производные бензо[g]хинолина для лечения глаукомы и близорукости
JP2007525527A5 (https=)
JP2003508513A5 (https=)
SE8804688L (sv) Substituerade styrenderivat
RU2005114905A (ru) Низкомолекулярные производные пептидов как ингибиторы взаимодействия ламинина/нидогена
EA200400756A1 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
ES2170758T3 (es) Antibioticos novedosos de cefalosporina y procedimientos para la preparacion de los mismos.
RU2008152372A (ru) Производные, родственные лизину, как ингибиторы аспартилпротеазы вич

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20121024